Uninsurance and Purchases of Prescription Drugs with High Rates of Misuse: Evidence from the Federal Dependent Coverage Mandate

DiNardi, Michael (2019): Uninsurance and Purchases of Prescription Drugs with High Rates of Misuse: Evidence from the Federal Dependent Coverage Mandate.

Abstract

Prescription central nervous system depressants, opioid pain relievers, and stimulants provide therapeutic value, but misuse for their recreational value is a growing problem in the United States. Because health insurance lowers the cost of purchasing prescription drugs, losing coverage may cause individuals to forgo treatment and decrease prescription drug consumption which could reduce health and increase the likelihood of overdose and death if individuals substitute to using illicit drugs. Using a regression discontinuity design, I estimate the effect of aging out of the federal dependent coverage mandate at age 26 on legal purchases of prescription central nervous system depressants, opioids, and stimulants. Individuals are 0.8-1 percentage points less likely to purchase a prescription central nervous system depressant and 1-2.6 percentage point less likely to purchase a prescription opioid after turning 26. These effects are strongest for women, while estimated effects for men are generally negative but imprecise.

• Item Type: MPRA Paper
• Language: English
• Keywords: health insurance, prescription drugs, substance abuse
• Subjects: I - Health, Education, and Welfare > I1 - Health > I13 - Health Insurance, Public and Private; I - Health, Education, and Welfare > I1 - Health > I19 - Other

References

Amuedo-Dorantes, C. and Yaya, M. E. 2016. The Impact of the ACA’S Extension of Coverage to Dependents on Young Adults’ Access to Care and Prescription Drugs. Southern Economic Journal, 83(1): 25-44.

Anderson, G. D. 2008. Gender Differences in Pharmacological Response. International Review of Neurobiology, 83: 1-10.

Antwi, Y. A., Moriya, A. S., and Simon, K. 2013. Effects of Federal Policy to Insure Young Adults: Evidence from the 2010 Affordable Care Act’s Dependent-Coverage Mandate. American Economic Journal: Economic Policy, 5(4): 1-28.

Barbaresco, S., Courtemanche, C. J., and Qi, Y. 2015. Impacts of the Affordable Care Act Dependent Coverage Provision on Health-related Outcomes of Young Adults. Journal of Health Economics, 40: 54-68.

Breslau, J., Yu, H., Han, B., Pacula, R. L., Burns, R. M., and Stein, B. D. 2017. Did the Dependent Coverage Expansion Increase Risky Substance Use Among Young Adults? Drug and Alcohol Dependence, 178(1): 556-561.

Calonico, S., Cattaneo, M. D., and Titiunik, R. 2014. Robust Nonparametric Confidence Intervals for Regression-Discontinuity Designs. Econometrica, 82(6): 2295-2326.

Compton, W. M., Jones, C. M., Baldwin, G. T. 2016. Relationship between Nonmedical Prescription-Opioid Use and Heroin Use. New England Journal of Medicine, 374: 154-163.

Compton, W. M. and Volkow, N. D. 2006. Abuse of Prescription Drugs and the Risk of Addiction. Drug and Alcohol Dependence, 83(1): S4-S7.

Dahlen, H. M. 2015. “Aging Out” of Dependent Coverage and the Effects on US Labor Market and Health Insurance Choices. American Journal of Public Health, 105(S5): S640-S650.

Darke, S., Hall, W., Weatherbun, D., and Brownwyn, L. 1999. Fluctuations in Heroin Purity and the Incidence of Fatal Heroin Overdose. Drug and Alcohol Dependence, 54(2): 155-161.

Hachtel, J. C. and Armstrong, K. J. 2019. Illicit Use of Prescription Stimulants: Gender Differences in Perceptions of Risk. Substance Use & Misuse, 54(10): 1654-1662.

Jones, C. M., Mack, K. A., and Paulozzi, L. J. 2013. Pharmaceutical Overdose Deaths, United States, 2010. Journal of the American Medical Association, 309(7): 657-659.

Jones, J. D., Mogali, S., and Comer, S. D. 2012. Polydrug Abuse: A Review of Opioid and Benzodiazepine Combination Use. Drug and Alcohol Dependence, 125(1-2): 8-18.

Lader, M., Tylee, A., and Donoghue, J. 2009. Withdrawing Benzodiazepines in Primary Care. CNS Drugs, 23(1): 19-34.

Lankenau, S.E., Teti, M., Silva, K., Bloom, J., Harocopos, A., and Treese, M. 2012. Initiation into Prescription Opioid Misuse Amongst Young Injection Drug Users. International Journal of Drug Policy, 23(1): 37-44.

Lee, J. 2018. Effects of Health Insurance Coverage on Risky Behaviors. Health Economics, 27(4): 762-777.

Lord, S., Brevard, J., and Budman, S. 2011. Connecting to Young Adults: An Online Social network Survey of Beliefs and Attitudes Associated with Prescription Opioid Misuse Among College Students. Substance Use & Misuse, 46(1): 66-76.

McCabe, S. E., Cranford, J. A., Boyd, C. J., Teter, C. J. 2007. Motives, Diversion and Routes of Administration Associated with Nonmedical Use of Prescription Opioids. Addictive Behaviors, 32(3): 562-575.

McHugh, R. K., Votaw, V. R., Sugarman, D. E., and Greenfield, S. F. 2018. Sex and Gender Differences in Substance Use Disorders. Clinical Psychology Review, 66: 12-23.

Muhuri, P. K., Gfroerer, J. C., Davies, C. 2013. Associations of Nonmedical Pain Reliever Use and Initiation of Heroin Use in the United States. CBHSQ Data Review. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from: https://www.samhsa.gov/data/. Accessed October 9, 2019.

Nicholson, J. L., Collinson, S. R., Mahato, B., Gould, E., Schoen, C., and Rustgi, S. D. 2009. Rite of Passage? Why Young Adults Become Uninsured and How New Policies Can Help, 2009 Update. Issue Brief (Commonwealth Fund), 64: 1-22.

Pakyz, A., Wang, H., and Cunningham, P. 2017. Impact of Health Reform on Young Adult Prescription Medication Utilization. American Journal of Managed Care, 23(11): 670-676.

Pisanu, C., Franconi, F., Gessa, G. L., Mameli, S., Pisanu, G. M., Campesi, I., Leggio, L., and Agabio, R. 2019. Sex Differences in the Response to Opioids for Pain Relief: A systematic review and meta-analysis. Pharmacological Research, 148: 1-11.

Olfson, M., King, M., and Schoenbaum, M. 2015. Benzodiazepene Use in the United States. Journal of the American Medical Association, Psychiatry, 72(2): 136-142.

Rabiner, D. L., Anastopoulos, A. D., Costello, E. J., Hoyle, R. H., McCabe, S. E., Swartzwelder, H. S. 2009. Motives and Perceived Consequences of Nonmedical ADHD Medication Use by College Students: Are Students Treating Themselves for Attention Problems? Journal of Attention Disorders, 13(3): 259-270.

Roe, C. M., McNamara, A. M., and Motheral, B. R. 2002. Gender- and Age-related Prescription Drug Use Patterns. Annals of Pharmacotherapy, 36(1): 30-39.

Schulenberg, J., Johnston, L., O’Malley, P., Bachman, J., Meich, R., and Patrick, M. 2019. Monitoring the Future National Survey Results on Drug Use 1975-2018: Volume 2, College Students & Adults Ages 19-60. Ann Arbor: Institute for Social Research, The University of Michigan.

Serdarevic, M., Striley, C. W., and Cottler, L. B. 2017. Sex Differences in Prescription Opioid Use. Current Opinion in Psychiatry, 30(4): 238-246.

Substance Abuse and Mental Health Services Administration. 2019. Key Substance Use and Mental Health Indicators in the United States: Results from the 2018 National Survey on Drug Use and Health (HHS Publication No. PEP19-5068, NSDUH Series H-54). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from: https://www.samhsa.gov/data/.

Wettstein, G. 2019. Health Insurance and Opioid Deaths: Evidence from the Affordable Care Act Young Adult Provision. Health Economics, 28(5): 666-677.

Yoruk, B. 2019. Health Insurance Coverage and Health Care Utilization: Evidence from the Affordable Care Act’s Dependent Coverage Mandate. Forum for Health Economics & Policy, 21(2): 1-24.